Latest Hematology Stories

Up to one-third of patients undergoing surgery in Ontario have a treatable form of anemia but are not optimally treated for it. A paper published online today in the Canadian Journal of Anesthesia says that hospitals that do treat patients with anemia have better outcomes, including fewer blood transfusions and infections and shorter hospital stays. A common option for management of anemia has been blood transfusion. But blood transfusions are expensive and are associated with higher...

The DrugRisk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Dallas, TX (PRWEB) January 24, 2013 The patient advocates at DrugRisk.com are alerting patients taking the birth control drugs Yaz or Yasmin of new information on the site showing patient claims over alleged blood clots from the drugs has now spread as far as Europe, as settlements continue in the United States....

[195 Pages Report] Apheresis Market report categorizes the global market into procedure, application (Plasmapheresis, Plateletpheresis & Erythrocytapheresis), technology, product type and end-user. (PRWEB) January 24, 2013 MarketsandMarkets recently conducted a study on the “Apheresis Market - Applications (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, Photopheresis), Procedures (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Devices...

PHOENIX, Jan. 24, 2013 /PRNewswire/ -- The Arizona Chapter of The Leukemia & Lymphoma Society and Avella Specialty Pharmacy announce they will present a day of discussion about the latest advancements, trends and management of oral chemotherapy medications. The free event will take place on Feb. 9, from 10:30 a.m. to 2:30 p.m., at SkySong, the ASU Scottsdale Innovation Center, 1475 N. Scottsdale Road, Scottsdale. Local hematology/oncology community members will provide...

EAST HANOVER, N.J., January 23, 2013 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved Exjade(®) (deferasirox) for the treatment of chronic iron overload in patients 10 years of age and older with non-transfusion-dependent thalassemia (NTDT) syndromes and with a liver iron concentration of at least 5 mg of iron per gram dry weight and a serum ferritin measurement greater than 300 micrograms per liter. Exjade is the first...

Johns Hopkins research suggests routine preventive measures won't stop all clots Despite receiving blood thinners and other clot prevention treatment, some patients still develop potentially lethal blood clots in the first month after their operations anyway, especially if they developed a surgical-site infection while in the hospital, according to results of a study at Johns Hopkins. The research, described in a report published in the Journal of the American College of Surgeons, found...

NEW YORK, Jan. 16, 2013 /PRNewswire/ -- On the court, Joe Johnson, star shooting guard for the Brooklyn Nets, is admired for the way he battles his opponents. Off the court, he looks to his mother for inspiration; she is afflicted with leukemia and fighting one of the toughest opponents to beat. (Photo: http://photos.prnewswire.com/prnh/20130116/NY43727) To support her and others battling blood cancers around the globe, the Brooklyn Nets and Delete Blood Cancer DKMS, the...

CRESSKILL, N.J., Jan. 11, 2013 /PRNewswire/ -- The trial date for over 1,000 NuvaRing lawsuits is being extended, feeding rumors that the vaginal ring contraceptive's manufacturer, Merck, may be ready to enter settlement negotiations. The lawsuits allege that NuvaRing caused serious side effects, including blood clots, deep vein thrombosis, pulmonary embolism, heart attacks, strokes, and wrongful death. The multidistrict litigation before Rodney W. Sippel of the U.S. District Court,...

COVINA, Calif., Jan. 10, 2013 /PRNewswire/ -- StemCyte, Inc. proudly announces the support of television host, producer and father, Mario Lopez. StemCyte offers parents an once-in-a-lifetime opportunity to bank their baby's cord blood. Umbilical cord blood stem cells are a potential cure for over 80 illnesses, including cancers, blood disorders, as well as immune and genetic diseases, with ongoing research continuing to bring about new disease treatments in regenerative medicine....

Sickle-shaped red blood cells target and destroy tumor cells and blood vessels The genetic mutation that causes sickle cell anemia also turns red blood cells into potent tumor killers and may offer a new way to treat some cancers that are resistant to existing treatments, according to research published January 9 in the open access journal PLOS ONE by David S. Terman of Jenomic Research Institute and colleagues from Duke University and other institutions. The mutation that causes sickle...